Sd-0006

Sd-0006

SCHEMBL5698573

Cl.Cl.O.O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncn2)CC1

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MAPK14

The experimentally established mechanism targets of Sd-0006. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
MAPK14 known ✓ Q16539 19/20 0.96
MAPK11 Q15759 19/20 0.96
MAP4K4 O95819 1/20 0.73
EGFR P00533 1/20 0.73
PRKACA P17612 1/20 0.73
FRK P42685 1/20 0.73
MAPK9 P45984 1/20 0.73
CSNK1A1 P48729 1/20 0.73
CSNK1D P48730 1/20 0.73
MINK1 Q8N4C8 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sd-0006 SCHEMBL5258003 0.99 MAPK11 (0.98) MAPK11MAPK14MAP4K4EGFRPRKACA
Sd-0006 SCHEMBL4891685 0.98 MAPK11 (1.00) MAPK11MAPK14MAP4K4EGFRPRKACA
SCHEMBL14411827 0.92 MAPK11 (0.88) MAPK11MAPK14MAP4K4EGFRPRKACA
SCHEMBL5257721 0.90 MAPK11 (1.00) MAPK11MAPK14MAP4K4EGFRPRKACA
SCHEMBL5255330 0.89 MAPK11 (0.83) MAPK11MAPK14MAP4K4EGFRPRKACA
Water SCHEMBL6173865 0.89 MAPK11 (0.79) MAPK11MAPK14MAP4K4EGFRPRKACA
SCHEMBL6175733 0.88 MAPK11 (0.81) MAPK11MAPK14MAP4K4EGFRPRKACA
SCHEMBL5256729 0.88 MAPK11 (0.80) MAPK11MAPK14MAP4K4EGFRPRKACA
Hydrochloric Acid SCHEMBL6174383 0.87 MAPK11 (0.78) MAPK11MAPK14MAP4K4EGFRPRKACA
SCHEMBL5256675 0.86 MAPK11 (0.79) MAPK11MAPK14MAP4K4EGFRPRKACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1682143-A2 COMBINATIONS COMPRISING AN HSP90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA Pharmacia Corporation (US) 2006-07-26 EP disclosed
WO-2005044194-A2 TREATMENT OR PREVENTION OF NEOPLASIA BY USE OF AN Hsp90 INHIBITOR PHARMACIA CORPORATION (US) 2005-05-19 WO disclosed
WO-2005041879-A2 COMBINATIONS COMPRISING AN Hsp90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA PHARMACIA CORPORATION (US) 2005-05-12 WO disclosed